US Senate Puts Brakes on Bill Targeting China-Based CDMOs Amid Stock Market Reactions
A US Congress bill aimed at prohibiting US-funded entities from engaging with various China-based contract...
A US Congress bill aimed at prohibiting US-funded entities from engaging with various China-based contract...
A bipartisan bill introduced on January 26, 2024, by members of the US House Select...
GlaxoSmithKline (GSK; NYSE: GSK), a UK-based pharmaceutical giant, has this week in-licensed US partner Elegen’s...
Hangzhou-based Glorious Med, a premier company specializing in gene detection for urinary system tumors, has...
Shenzhen Mingyi Zhizao Technology Co., Ltd, a Chinese company specializing in the gene sequencing industry,...
Haplox Biotechnology Co., Ltd, a Chinese biotech firm, and US industry leader Illumina (NASDAQ: ILMN)...
US-based life sciences service provider Bio-Techne Corporation (NASDAQ: TECH) has released its Q1 report for...
The Structural Genomics Consortium (SGC) of Canada has announced a strategic partnership with China-based HitGen...
Singapore-based Vela Diagnostics, a global leader in integrated molecular solutions for diagnosing infectious diseases and...
Precision medicine specialist Lucence, with a presence in Suzhou, Hong Kong, and Palo Alto, California,...
China-based MGI Tech, a subsidiary of BGI Group (SHE: 300676), has entered into cooperation agreements...
Shenzhen-based DNA sequencer specialist, GeneMind Biosciences Co., Ltd, has reportedly raised RMB 400 million in...
South Korea-based molecular diagnostics firm Novomics Co. has announced a strategic partnership with China-based Hubei...
China-based genomics leader BGI Genomics Co., Ltd (SHE: 300676) has entered into a memorandum of...
This week, leading pharmaceutical companies AbbVie (NYSE: ABBV), Amgen (NASDAQ: AMGN), AstraZeneca (AZ; NASDAQ: AZN),...
Helio Genomics has announced that its ‘sister company’ Laboratory for Advanced Medicine & Health Group...
US-based AbbVie Inc., (NYSE: ABBV), the company behind the first-in-class Bruton’s tyrosine kinase (BTK) inhibitor...
Azenta Life Sciences (NASDAQ: AZTA) has entered into a global partnership with China-based Vazyme Biotech...
Suzhou Basecare Medical Co., Ltd (HKG: 2170), a China-based in vitro fertilization (IVF) specialist, has...
Shanghai-based Sequanta Technologies, a leading multi-omics research and clinical service provider, has announced a strategic...